Clover 医疗

最新新闻

• 评级变动
  CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $3.2
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Raises Target Price to $5.5
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  Craig-Hallum Maintains Clover Health(CLOV.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2025/10/10
• 评级变动
  CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $4.1
  \u5e02\u573a\u8d44\u8baf · 2025/9/8
• 评级变动
  CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Cuts Target Price to $3.2
  \u5e02\u573a\u8d44\u8baf · 2026/3/20
• Deutsche Bank Initiates Clover Health(CLOV.US) With Buy Rating, Announces Target Price $6
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $5.5
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  Craig-Hallum Maintains Clover Health(CLOV.US) With Buy Rating, Announces Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2025/8/7
• 评级变动
  Leerink Partners Maintains Clover Health(CLOV.US) With Hold Rating, Raises Target Price to $3
  \u5e02\u573a\u8d44\u8baf · 2025/10/22
• 评级变动
  CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $4.5
  \u5e02\u573a\u8d44\u8baf · 2025/5/8
• 评级变动
  UBS Maintains Clover Health(CLOV.US) With Hold Rating, Cuts Target Price to $2.75
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• 评级变动
  UBS Maintains Clover Health(CLOV.US) With Hold Rating, Cuts Target Price to $3
  \u5e02\u573a\u8d44\u8baf · 2025/8/7
• 评级变动
  Leerink Partners Maintains Clover Health(CLOV.US) With Hold Rating, Cuts Target Price to $2.5
  \u5e02\u573a\u8d44\u8baf · 2025/8/9
• 评级变动
  CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Cuts Target Price to $4.1
  \u5e02\u573a\u8d44\u8baf · 2025/8/7
• 评级变动
  CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Cuts Target Price to $3.7
  \u5e02\u573a\u8d44\u8baf · 2025/11/6
• Deutsche Bank Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $6
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• 评级变动
  Leerink Partners Maintains Clover Health(CLOV.US) With Hold Rating, Maintains Target Price $2.5
  \u5e02\u573a\u8d44\u8baf · 2025/8/12
• CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Raises Target Price to $4.2
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Clover Health Investments (CLOV) and Xilio Therapeutics (XLO)
  TipRanks · 2025/8/15
• 评级变动
  CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $3.7
  \u5e02\u573a\u8d44\u8baf · 2026/2/28

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。